Pura Vida Investments, LLC Affimed N.V. Transaction History

Pura Vida Investments, LLC

  • $29.1 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$7.78 - $11.4 $1.87 Million - $2.74 Million
-240,542 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$5.12 - $8.48 $719,575 - $1.19 Million
140,542 Added 140.54%
240,542 $1.9 Million
Q4 2020

Feb 16, 2021
BUY
$3.16 - $7.03 $316,000 - $703,000
100,000 New
100,000 $582,000

Others Institutions Holding AFMD

# of Institutions
3
Shares Held
1.09M
Call Options Held
0
Put Options Held
0
View Full List

About Affimed N.V.

AFMD Quotes by TradingView
  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $155M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email